Talkspace is helping employers promote mental health benefits

The latest stories trending on MedCity News.

Editor's Pick

Top Story Talkspace Launches New Mental Health Portal for Employers Talkspace's new product, Talkspace Engage, aims to help employers promote their mental health benefits to their employees. It allows employers to easily share mental health resources and virtual classes led by Talkspace clinicians. Startups Get in Front of These Investors - Here's How: Sofia Guerra, Investor, Bessemer Venture Partners and Harry Glorikian, General Partner, Scientia Ventures   There is no fee to apply. Only companies funded from 2018-2022, and that have raised a seed funding round will be considered. Startups can apply to only one track. There are five tracks and each track will feature six finalists. Application Deadline: February 28, 2023. Selections will be announced on March 22, 2023.   Apply Now

Featured News

Is Interoperability Tech Worth the Investment? Experts Say Yes for 3 Reasons Panelists at a recent healthcare conference expressed optimism about the automation technology that health plans, pharmacy benefit managers and providers can adopt to facilitate real-time data sharing. They said that such technology has potential to improve medication adherence, reduce costs and save time for both providers and payers. How to Rein in Unpredictability During High-Traffic Respiratory Illness Season Making operational changes to ease the unpredictable nature of respiratory season is the right thing to do for staff, for patients, and for the business. Digital solutions and better processes allow staff to work smarter and faster and prepare them for high-volume days ahead of time so they feel in control. Moderna Flu Vax Prompts Response to More Common Strains, But Misses in Influenza B Moderna's mRNA vaccine for influenza has early data from a pivotal study showing it met trial goals assessing immune response against the more common strains of the virus, but missed against two less common types. A separate and ongoing Phase 3 study is assessing efficacy. Health Transformation Alliance Teams up With Cognoa for Autism Diagnostic Device Cognoa's Canvas Dx product is authorized by the Food and Drug Administration and assists healthcare providers in diagnosing autism spectrum disorder for children ages 18 months through 72 months. Members of Health Transformation Alliance can now add Canvas Dx to their benefit plans. Cell Therapy Biotech Talaris Ends Two Kidney Transplant Trials, Restructures While Talaris Therapeutics is ending two clinical tests of its cell therapy in kidney transplant patients, a third study in the autoimmune condition scleroderma is continuing. Meanwhile, the biotech's restructuring plan is pursuing "strategic alternatives" that could include a merger or sale. 3 Conditions that Must be Met to Make Interoperability a Reality am suggesting we invest our efforts to think beyond our current solutions and reimagine what true interoperability could look like in an ideal healthcare ecosystem. Can we make progress in reimagining how healthcare works in 2023? I believe we can. We must. We will. Digital as the Differentiator for Biopharma and Medtech Pharma players, now more than ever, need a new and powerful tool to differentiate their products. We believe the next decade of transformation is digital.

Resources

Startup 101: Providing Best Practices for Healthcare Entrepreneurs Get the tools necessary to make the right decisions, know what strategies to avoid, and learn how to approach potential healthcare customers.   Download Now

MedCity News • 611 Broadway • New York, NY unsubscribe